Transcriptional Regulator BPTF/FAC1 is Essential for Trophoblast Differentiation During Early Mouse Development
Overview
Affiliations
The putative transcriptional regulator BPTF/FAC1 is expressed in embryonic and extraembryonic tissues of the early mouse conceptus. The extraembryonic trophoblast lineage in mammals is essential to form the fetal part of the placenta and hence for the growth and viability of the embryo in utero. Here, we describe a loss-of-function allele of the BPTF/FAC1 gene that causes embryonic lethality in the mouse. BPTF/FAC1-deficient embryos form apparently normal blastocysts that implant and develop epiblast, visceral endoderm, and extraembryonic ectoderm including trophoblast stem cells. Subsequent development of mutants, however, is arrested at the early gastrula stage (embryonic day 6.5), and virtually all null embryos die before midgestation. Most notably, the ectoplacental cone is drastically reduced or absent in mutants, which may cause the embryonic lethality. Development of the mutant epiblast is also affected, as the anterior visceral endoderm and the primitive streak do not form correctly, while brachyury-expressing mesodermal cells arise but are delayed. The mutant phenotype suggests that gastrulation is initiated, but no complete anteroposterior axis of the epiblast appears. We conclude that BPTF/FAC1 is essential in the extraembryonic lineage for correct development of the ectoplacental cone and fetomaternal interactions. In addition, BPTF/FAC1 may also play a role either directly or indirectly in anterior-posterior patterning of the epiblast.
BPTF promotes glioma development through USP34-mediated de-ubiquitination of FOXC1.
Pan Y, Yuan F, Lin Z, Li Y Histol Histopathol. 2024; 40(2):205-214.
PMID: 38686761 DOI: 10.14670/HH-18-748.
Bromodomain inhibition targeting BPTF in the treatment of melanoma and other solid tumors.
Khan I, Kashani-Sabet M Clin Exp Metastasis. 2024; 41(4):509-515.
PMID: 38683257 DOI: 10.1007/s10585-024-10265-7.
BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target.
Bezrookove V, Khan I, Nosrati M, Miller 3rd J, McAllister S, Dar A Front Oncol. 2022; 12:1011173.
PMID: 36530982 PMC: 9748419. DOI: 10.3389/fonc.2022.1011173.
Via Y Rada R, Daniel N, Archilla C, Frambourg A, Jouneau L, Jaszczyszyn Y Cells. 2022; 11(23).
PMID: 36497026 PMC: 9736044. DOI: 10.3390/cells11233766.
Wu W, Chen R Mol Genet Genomic Med. 2022; 11(1):e2066.
PMID: 36153657 PMC: 9834177. DOI: 10.1002/mgg3.2066.